Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I know the stock had been bouncing between $ 2 and $ 4, but what the actual f&*k is this 78-cent pricing all of a sudden???
Does anyone know of recent developments that would have caused this? (Other than our luck?)
Take care, Jim
October 10th was almost a dollar higher than today, then a drop, then $ 3.89 in the same week.
And with no announcements, SEC releases, etc to explain the huge jumps.
Is anyone seeing anything that explains this?
Thanks, Jim
I am one of those long-term guys you mention. I researched it for about a year in 2014. Bought in in early 2015 with an initial investment of $ 12,000. There was a point when CNBX had around $ 8,000 left in operating capital. A year or so later, over thirty-five million dollars in the war chest. Two approved drugs, multiple promising studies, the price was going from pennies to dollars.
In February of 2017, I had sold some over time as it had gone over $ 3 a share, but suddenly shot to $ 7.48 a share and I had $ 250,000 to show for my investment. I of course thought we were in great shape, as it had been going up for months.
Then an article was written saying the meteoric rise was drawing SEC scrutiny. If the writer were an honest man, he would have acknowledged all stocks that rise that fast are reviewed by the SEC, but he chose to make it sound ominous.
We rode the $ 7 for a few days and then plummeted and you cannot even find that price listed in the history of the stock on those dates on most financial pages.
It's amazing what some misleading press can do. And with that, they have just bungled again and again.
I agree, it does seem dead.
Take care, Jim
WOW!! 1/3rd of our value in a day? Does anyone know of news that justifies us suddenly leaving $ 3 to $ 4 range?
I cannot get over that they got away with the 120 to 1 trade off. And Etrade charged around $ 35 per account for the change, so anyone like me that also had to pay that really took a beating on top of the beating.
The hits just keep on coming.
Take care, Jim
Anyone else getting a PAGE EXPIRED page when you try to post a comment?
My wife talked me into doing the same.
I made the mistake of getting back in by doing the normal buy in December when everyone sells to capture their losses and the price drops and planned to sell in the new year when it went back up, which has been a good strategy for many years, but I had not heard about the split.
So I got back in at the wrong time. With the money I had invested for 25,000 shares that are now 200 shares, I could have waited and with the same money had around 600 to 800 shares.
I just wish I had dumped it back in 2017 when it went above $ 7. I had around 36,000 shares. For about 3 days in February 2017, I was the richest I had been in my life.
Woulda, coulda, shoulda... and on we go.
Take care, Jim
"And not good toast like cinnamon toast, but burnt toast". I love that clarification!!!
I am still waiting for all of the activities they have done to reveal any kind of a good idea.
I at least hoped they would stay above $ 5 and no longer be a "penny" or OTC or pink stock, but they have basically stayed all of those while reducing my 25,000 shares to around 200 shares.
Had my 25,000 gone to $ 10, it would be worth something.
If my 200 shares go to $ 100, which we will never see, it is worth nothing compared to my time and investment.
But glad they spent all the time and money and gave us a heads up!!!
Thanks for replying and take care! Jim
Several days of sitting at $ 3.75 with no chart, no activity. No High, no Low. Did they halt trading?
Thanks, Jim
WOW!!! I did not see it bouncing back like it did today!!
It closed at close to $ 4 yesterday and is sitting at $ 5 right now.
Fantastic!! Jim
No, I had bought in at ten cents before the end of the year and had felt forty cents was a good sell point, as February usually gets up between forty to sixty cents, so I set my order and figured it was good to go.
They then do the split, and suddenly my order is somehow locked up, with a price well above forty cents but shares that cannot be sold due to being held up.
I would have thought that they either would have canceled the order due to the split or executed the order since it got above forty cents.
I have been "churning" this each February since circa 2015 and it did a nice return each year by dumping in fall, buying back in before new year to catch the February up swing. The split screwed all of that up.
Thanks and take care, Jim
I had an open order to sell at 40 cents since December and since the split Etrade says that it is too late to execute the sell order.
Does anyone else have this issue or experience with it?
I am trying to sell and while it no longer recognizes the order as open so as to be able to cancel it, it also will not allow me to cancel it as it is past being able to... ???
I cannot figure out why when it was over 40 cents it didn't execute, but beyond that, now has me locked in.
Please advise if anyone else has this issue and if you resolved it, how.
Thank You, Jim
Yeah, we're sitting at about a nickel per share based on where we'd be pre-split with the math being what it is.
I've had mine set to sell off if it hit 40 cents since back in January. I'd love to know why it didn't sell off when it obviously went above 40 cents after the split.
Either they cancel outstanding orders in a split or it is because if you google CNBX instead of CNBXD it still shows the stock at 8 cents and so Etrade has not registered that we are currently in dollars.
Take care, Jim
RE: Chart Inactivity 5-25-22 Did anyone else notice most if not all sites did not have chart activity for Cannabics Wednesday 5-25?
They had the price at $ 6.14 but no open, high, low, etc.
Can anyone explain why?
Thanks, Jim
Hi GoSing,
I got out for a while last year and came back for the traditional end of the year/beginning of the year trends.
I used to stay up to date but haven't as of late. Anything of interest in the pipe? (Puns always intended!!!).
Thanks for your kind words and good to see you as well. Sorry it took me so long to reply.
Take care, Jim
Hi Pierpont,
RE: "1) change name to CNBX Pharmaceuticals - Easier to say, easier to search, easier to find stock symbol"... I have been gone a while. What other name was involved/being considered?
Per your point in # 4, I agree, I came back before the end of the year as I see people sell off to capture their loss and buy back in. I of course hoped for the traditional February bump, but not seeing that this year.
Anything of interest happening?
Take care, Jim
Hi GoSing, Thank you for weighing in and for the info! As we near the date, please advise if you hear any different.
Thanks again, Jim
Does anyone have any input or insights regarding CNBX and the change to OTC and penny stock laws coming in September?
I have posted a link to the expected changes below. Interested in any news anyone has heard.
Thanks, Jim
https://www.securitieslawyer101.com/2021/what-you-need-to-know-as-the-september-28-amended-rule-15c2-11-date-approaches/
Thank you for your efforts!!! If nothing else, ask your friend her thoughts on CNBX and if she has any thoughts or info on Itamar being removed.
Thanks again!! Jim
In his position as Chairman and as a Board Member, he would not have direct access to funds to be embezzling. The only way he could have gotten money would have been through an act or acts that others approved but were not aware were benefitting him. That would be an extremely odd and rare situation.
My guess is it has something more to do with something he did in his personal life or something he said that the company did not approve of.
The sad thing is the best communication investors ever had were the years that Itamar was CEO. If you emailed CNBX, he would reply personally, answering questions, advising of upcoming conventions that would be of interest to your question, and asking questions about you and your investing, etc.
Eyal has never been as good with PR as Itamar was. 2014 through 2017 were the best years. 2018 on has been a puddle of info here, a raindrop of a press release there, and the price reflects that. I would guess there are those that do not know CNBX has products in the market, like the long release tabs, the 5mg tabs, etc.
There was a time that the company and the distributors were both doing press releases and happily advertising that they had CNBX products available for sale, how to get them, etc. It wasn't Wal Mart selling big screen tv's type dollars, but it was good press and an income stream. Even the income stream of the home grow systems CNBX partnered with have no longer been mentioned. Heard anything good about Seedio lately? They bragged about that instead of their own products and then that news dried up pretty quickly. It moved some money around circa 2019, but short term.
I miss Itamar. I miss the money made under Itamar. I would love to know why they asked him to leave.
Take care, Jim
Yeah, until 2018 he was CEO. He chose to resign that year.
In October of last year, they brought him back as Chairman and a Board Member.
Sept. 2nd they forced him to leave the company.
I hope your friend gets better, sorry to hear about her surgery. Am I correct that she does a podcast regarding marijuana? Does she get to pick her topics? If so, when she comes back, I thought she might want to file a Freedom of Information Act request of why they made him leave and discuss it on her show.
I have been invested in CNBX since early 2015, having researched them a good part of 2014. When Itamar was CEO, he was great about replying to emails, showing interest in investors, etc. I think they had around $ 8,000 in cash when I first invested. They have since reached millions, but the change of CEO seems to have changed their communication, etc.
Has your friend ever said what she personally thinks of CNBX? Even if she hasn't discussed it on the show, I wondered if she had researched them at all and if she followed their work what she thought of them.
Have a great weekend! Jim
Hi XWAVXALMIMAN,
Please ask your MJ podcast friend if she has any freedom of information act pull on finding out why they removed Itamar Borochov from their board September 4th per the SEC filings that were posted.
Other than the SEC posts, there has been no news of it that I can find.
I would think a company removing its founder from the board may be of interest to her as a story and, hopefully, we can get some explanation.
Thank you for your and your friend's time!! Jim
It's Dow Jones, so it carries some weight. We have to decide if it is a big deal or moving the cards around...
Hopefully, it gets picked up by someone that writes articles, gets vetted, and gets some momentum.
Cannabics Pharmaceuticals to Establish a Division for its Antitumor Drug Candidate RCC-33
9:00 AM ET 8/20/20 | Dow Jones
TEL AVIV, Israel and BETHESDA, Maryland, Aug. 20, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it is establishing a dedicated division for the development of its Antitumor Drug Candidate RCC-33 for the treatment of colorectal cancer.
The announcement comes as the company is gearing up to expand its clinical validation efforts for its RCC-33 formula, and is already preparing a plan for the next steps in its clinical validation path, including in-vivo experiments, collaborations with key medical centers, and the preparation of a product dossier with which the company plans to schedule a Pre IND Meeting with the FDA.
Eyal Barad, Cannabics' CEO commented: "The development of our drug candidate for the treatment of colorectal cancer based on our novel and proprietary formulation RCC-33 has become a central strategic activity for the company. Up until now we have conducted various POC experiments in our in-house drug discovery facility, and at this time, the company has decided to establish a dedicated division to centralize, coordinate and lead all aspects of the development of its drug candidate going forward. Our Scientific Advisory Board Member Dr. Erez Scapa has accepted the position of Medical Director for the new RCC-33 division and assist the company in its forthcoming plans for clinical validation. This is indeed exciting news for the company."
Dr. Erez Scapa commented: "I thank the company for their trust and am looking forward for the opportunity to drive a comprehensive clinical validation plan for the company's drug candidate RCC-33 for colorectal cancer. As a gastroenterologist, I am aware that currently over 65% of treated colorectal cancer patients survive for 5 years or more in the US. While we are still in the early stages of a long and challenging path, the mere possibility to demonstrate even a modest positive impact for these patients, gets me excited and motivates me to undertake the challenges ahead."
About Cannabics Pharmaceuticals
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) is a U.S public company that is developing a platform that leverages novel drug-screening tools to create cannabinoid-based therapies for cancer that are more precise to a patient's profile. By developing tools to assess effectiveness on a personalized basis, Cannabics is helping to move cannabinoids into the future of cancer therapy. The Company's R&D is based in Israel, where it is licensed by the Ministry of Health to conduct scientific and clinical research on cannabinoid formulations and cancer. For more information, please visit www.cannabics.com. For the latest updates on Cannabics Pharmaceuticals follow the Company on Twitter @Cannabics, Facebook @CannabicsPharmaceuticals, LinkedIn, and on Instagram @Cannabics_Pharmaceuticals.
Disclaimer:
Certain statements contained in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other U.S. Federal securities laws. Such statements include but are not limited to statements identified by words such as "believes," "expects," "anticipates," "estimates," "intends," "plans," "targets," "projects" and similar expressions. The statements in this release are based upon the current beliefs and expectations of our Company's management and are subject to significant risks and uncertainties. Actual results may differ from those outlined in the forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, results of clinical trials and other studies, the challenges inherent in new product development initiatives, the effect of any competitive products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future that is necessary to maintain our business, changes in government policy and regulation, potential litigation by or against us, any governmental review of our products or practices, as well as other risks discussed from time to time in our filings with the Securities and Exchange Commission including, without limitation, our latest 10-Q Report filed July 14(th) , 2020. We undertake no duty to update any forward-looking statement or any information contained in this press release or other public disclosures at any time. Finally, the investing public is reminded that the only announcements or information about Cannabics Pharmaceuticals Inc., which are condoned by the Company, must emanate from the Company itself and bear our name as its source.
For more information about Cannabics:
Cannabics Pharmaceuticals Inc.
Phone: +1(877)424-2429
info@Cannabics.com
http://www.Cannabics.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/cannabics-pharmaceuticals-to-establish-a-division-for-its-antitumor-drug-candidate-rcc-33-301115652.html
SOURCE Cannabics Pharmaceuticals Inc.
/Web site: http://www.Cannabics.com
> Dow Jones Newswires
August 20, 2020 09:00 ET (13:00 GMT)
MMJ is an abbreviation for Medical Marijuana.
As for a contact to get a guest for the show, go to their website and look for their contacts list.
When I used to write for MMJ the then CEO of CNBX would reply to me personally at times. Those days may be way gone, but I would think they will advise who will do a call-in, etc.
Good luck and please let us know if your friend is interested and vice versa if CNBX is interested.
Take care, Jim
Whether she gets CNBX on the show or not, please advise us of her interest in doing so.
If she does MMJ play by play for a living and has no interest in talking to them, that would be of interest to us here!!
Thanks, Jim
Thank you WallyWest for one of the most in-depth posts we have had on here in quite awhile.
Not knocking anyone else, I am brief at times as well, but I miss the days of long, research based posts.
Thank You! Jim
Hi Dinan m4, Glad to help!! I used to do research and wrote regularly for CNBX and shared a lot here.
Search for posts by Jim992 and you can track my writing, I believe, back to around 2015.
Take care, Jim
It actually has. it is just the years of clinical trials it takes to get any product FDA approved.
It has a number of products that will probably lead the way when they start putting people on MJ regularly. Their 12 hour long release capsule is the most Human Resources friendly, meaning your company will allow you to be on something you take at home but will not allow you to bring it to work because how do they prove you are not selling it? Most other companies products are taken at 4 hour intervals. Try getting that past Human Resources.
Their products for stomach ulcers, cancers, etc have all had 100% success. But they have to do them again, and again, and again, on patients for years, and that is what will take time.
Take care, Jim
Dinan m4 - I am not sure what you were replying to, but "dipshit posting" is my new favorite catchphrase!!! LOL!!!
Thanks for all the posts noting the purchases over the last couple days. I used to be a lot better about keeping up with research here but have fallen off as of late. I greatly appreciate your concise updates!!
Jim
In my opinion, they have the employees in place and the structure between here and overseas to do what they have to do.
What they are avoiding, and the reason you are reading actual news instead of publicity news from them, is because they are going to keep this stock below a consistent $ 5 until they are certain they are ready to change boards.
The board they trade on now is $ 5.00 and below. To go to the big board, a consistent $ 5.00 and above, they will want to have taken advantage of every supplier, every contract, etc, etc before they are viewed as a company to charge higher costs to.
For example: If you buy a product regularly under the name Mike's Auto Repair, you will probably pay a certain price. If you order under the name General Motors or Ford Motor Company, you might get price gouged. To argue that this doesn't happen is to say that our government doesn't get taken advantage of by their suppliers even though they are the US Government. $ 700 toilet seat, anyone?
I think this is a big part of it. They are avoiding going big before they have accomplished a certain number of things so they are not held over the buy out fire or forced to pay higher costs.
Take care, Jim
Do you still have the info you reference in your post?
Thank You, Jim
I wasn't logged on to see how long it was at .29, but I had a 60-day limit order in at .30 and it filled 410 shares at .2999 and then must have gone up because it didn't fill further and closed at .32
I know not everyone is happy with the yo-yo bounce, but as noted in other posts, buy on the down days and you will see a profit.
I picked up 12000 shares when it was at .15 so I have doubled that money and made ten percent by close just on the money I invested today. You can do this, but you have to be willing to ride the coaster. Get comfortable with that and you will see return percentages that no savings accounts are paying.
As others have said, do not invest money you cannot leave locked up here for a while.
I am not a pro, I am not giving investment advice, I am just stating the facts of how this has been going.
Hopefully, a little more bouncing around and then back up above .50
Take care, Jim
Thanks for the quick reply. I saw posts regarding the MJ industry a few posts down and thought maybe something regarding the industry had been released.
I figure "first of the year folks" that are in for a quick buck are selling off and after the dip we will run as we get closer to the election. 2016 is the blueprint for this particular year and any given year you can follow the rise and fall by the calendar.
I sold at a loss in December to claim it on my taxes. I waited 35 days to make sure it registered as past 30 days, and then I bought back in on the lull.
The 35 days made me an extra 765 shares for no cost except the $ 6.95 x 2 E-Trade sell and buy price to get out and back in, which was paid for out of my end of year sale proceeds.
It is illegal for a broker to do it for you because they collect a commission and it looks like they are churning sales just for commission. As an individual, it is legal and a good investment as it is like free money at the end of the year for the "loss" on your taxes and then a cheap buy-in at the beginning of the year during the lull.
As always, I am in no way a pro, and I am not giving advice, but the more years I do this, the more I like to share my story because we might as well all help each other out if the calendar is going to do the heavy lifting.
Have a great weekend and take care, Jim
What scam? Is this a throw-away comment regarding today's drop or something regarding the industry?
Do you have a link to a scam news release?
I'm a research guy so any time someone references something if you would provide a link with it, I know we all appreciate it.
Take care, Jim
Good News About This Being An Election Year:
The last time this stock went through a full-scale election year was 2016.
In June of 2016, CNBX was sitting at 5 cents a share.
A small number of states started talking legalization, and by November 2016, CNBX was at 81 cents a share. By February it was over $ 7.
(CNBX burst its own bubble when it went above $ 7 to avoid having to grow too quickly at a time when lack of legalization was a hindrance, and the stock, of course, came way back down over the last 4 years, but we have an election year once again, so please read on).
From the 2016 stats above, jump 4 years ahead to 2020. Per the article below, not a small number, but instead 40 states are considering some form of legalization by the end of 2020 and that is pressuring Congress for federal legalization.
Legalization turned 5 cents into seven dollars by the beginning of 2017. It is poised to do it again. The more it is in the news, the more people are going to consider voting for it and investing in it, and the push for federal legalization moves forward.
As I like to call it, we are riding the "Calendar Coaster". It happens every year, and with legalization and elections, we are poised to recreate 2016 in a big way.
What was 5 cents in June 2016 will probably be closer to 50 cents this June. If the math of it having grown tenfold in four years holds, what was 81 cents a share in 2016 is going to be $ 8.10 a share in November 2020.
If the math truly replicates 2016, come February 2021, what was 50 cents a share in June 2020 will be $ 70 a share in February 2021 (.05 x 140 = $ 7 so .50 x 140 = $ 70).
Now, will the math work out exactly? What ever does? But even if 50 cents goes to just $ 4, it is an amazing return. If CNBX gets anywhere near $ 40, it will be life-changing for many of us. The election calendar is in our favor and the math is almost exactly 10 times what it was 4 years ago. A fraction of this is a huge success.
We are only going to have so many election years where legalization is on the table. At some point what is unfathomable now will be the norm, much like being able to buy alcohol in 2020 is a bit easier than in 1920. Who would have thought during prohibition that we would have state liquor stores and groceries selling alcohol? That day will come, and we are at the forefront of it right now, both medicinally and recreationally, and medicinal will lead the way.
To many of you, it probably sounds like I am preaching to the choir, but for anybody who was not in CNBX in 2016, I want to share the importance of what is happening in 2020. It is another and even bigger chance to do the same thing as 4 years ago. This election year can turn pennies to dollars quickly.
I am in no way an advisor, but at this point, I am a bit of a CNBX historian.
I wish you all the best. Just one of many articles regarding 2020 is below.
Take care, Jim
https://www.politico.com/news/2020/01/20/marijuana-legalization-federal-laws-100688
Your question of how much they may be holding back is a good one.
I have researched CNBX since 2014, been in since 2015, and here is what I have gleaned regarding your question:
1. Take a look at the high-level people they have hired since 2017. People that are highly regarded in their field are dedicating their time to CNBX, but quietly. We are not seeing these people appear at conventions, etc.
2. Look at how hard they have worked to keep the price below $ 5 so that they can continue their work without being forced onto the "big board" where they would be put in a "perform or get off stage" position. They hit $ 7.46 at the end of February 2017 and if they had continued to rise, they would have been asked to move from OTC to the Big Board and they would have had to have been ready to be Anheuser Busch or ended up being Strohs at best.
3. They have hired too big of guns to continue to live below $ 5.00 forever.
4. They are working hard to bide their time, get products tested, approved, accepted by doctors, etc. An example is their long release pill over GWPH's 4 hour spray. With the spray, it can spill in a purse, etc. You have to take in to work to take every 4 hours, and companies DO NOT have to agree to let you bring such products on their property, regardless of if they are legal.
In short, think of the Human Resources side of the 12 hour pill. You take it before and after work, and do not have to take it to work. It is a no mess product, no spills in a purse, etc. Which one would your mother be more apt to accept from her doctor; a spray or a pill? Those are the questions CNBX is asking and trying to have answered before they are a big board company.
In the meantime, we get to enjoy the "Calendar Coaster". The stock is going to go up into dollars, and then people are going to get out to capture their gains, sell some at a loss at the end of the year to help with taxes, buy back in in January, and be back at dollars by the time warm weather hits. Ride the coaster, make a buck, but always have some in for when they take off.
That is what I have done since 2015 and it has been the best stock I have been invested in. That portfolio includes: Lionsgate (rode it from $ 15 to $ 40 and got out), Netflix, and other big board as well as some small board tickers. This has performed the best.
I am not giving advice, just giving my opinion on your question and sharing my time in CNBX.
Take care, Jim
You have touched upon something I cannot figure out:
The high you mention was $ 7.46 in February 2017. But if you look up the history of the company, charts show the high in the $ 4 range. ???
That would make sense if they had ever split the stock, as Netflix for example shows a modified history after their split, not showing the actual dollar amount it reached. But from 2014 to today, CNBX has never went on record as doing a stock split, so I cannot figure why they do not show the $ 7.46 high.
Anyone want to weigh in on that? Bueller, Bueller... :)
Thanks and take care, Jim
Hi Matt, good to see you too. Yeah, unless there are those that have been checking in since 2014 but do not post, I would say we are probably the longest running "members" here right now.
A February 2017 is brewing in some ways. It will be very interesting to see if we hit anywhere near $ 7.46 again or if we even surpass it based on more states legalizing, etc.
Take care, Jim
Hi Matt, good to see you too. Yeah, unless there are those that have been checking in since 2014 but do not post, I would say we are probably the longest running "members" here right now.
A February 2017 is brewing in some ways. It will be very interesting to see if we hit anywhere near $ 7.46 again or if we even surpass it based on more states legalizing, etc.
Take care, Jim
Yeah, Wash Sale is the common term.
My mistake in typing "white".
Take care, Jim
Yes, here is how it works and why it is at the end of the year:
You cannot sell a stock at a loss and claim that loss on your taxes if you buy back in within a 30 days. That is a "wash sale" by definition.
SO, when a stock like CNBX is down, we all want to sell before Dec. 31st to capture the loss on that year's taxes before Dec. 31st. (You are allowed to write stock losses off as long as they are not in an IRA, 401K, etc. They are just invested in a normal account).
So, we all want to capture our loss on our taxes at the end of the year.
However, most of us time it knowing that people sell off the most around the end of November/beginning of December, so the 30 days will be up (Wash Sale Rule negated) and we can buy back in as soon as new years hits, (ie, the new tax year has started) because that is how people do it, and we want to get back in before people buy and the price jumps.
To give you an example: I sold shares at 20 cents and bought back in at 12 cents just over a month later, almost doubling my share count of the shares I sold without investing any money. Those shares have now jumped from the 12 cents that I bought back in at to around 38 cents, tripling my buy in price. So, I basically doubled my share count by selling at 20 and buying back in at 12, and then that 12 more than tripled. In effect, I doubled my shares, and then tripled their value.
On an account holding $ 1,000 on November 30th, you would be holding around $ 6,000 now, based on this model. And the beauty is, it happens every 12 months because of how the calendar works and how tax law works.
I am not giving advise. I am not a professional. I am simply sharing my understanding of how "Wash Sales", tax law, etc work.
It dropped because people expected others to get out, it rose because people expected others to get back in. Some refer to it as FOMO, Fear Of Missing Out. But in reality, it is the calendar and tax law.
Take care, Jim